GEN Exclusives

More »

GEN News Highlights

More »
Mar 24, 2009

Bio-Rad and Bruker Ally to Develop Biomarker Discovery Tools

  • Bio-Rad Laboratories and Bruker are combining technologies for high-throughput protein profiling and identification. The exclusive agreement includes the development and marketing of new products based on Bio-Rad’s surface-enhanced laser desorption/ionization (SELDI) technology in combination with Bruker’s matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF/TOF) mass spectrometers.

    The products will provide solutions for biomarker discovery, in particular, the detection and high-confidence identification of intact peptides and proteins under 30 kilodaltons. These are challenging for currently available technologies to identify, according to the companies.

Related content


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

Disclosing Clinical Trial Data

Do you believe that conducting performance audits for new drugs will incentivize pharma firms to become more transparent?

More »